Promising Therapeutic Strategy for Alzheimer’s Disease Based on Specific Immune Cells

Promising Therapeutic Strategy for Alzheimer’s Disease Based on Specific Immune Cells
Researchers at Cedars-Sinai Medical Center recently published in the journal Brain a new promising immune therapeutic strategy for Alzheimer’s disease using mice models. The study is entitled “Therapeutic effects of glatiramer acetate and grafted CD115+ monocytes in a mouse model of Alzheimer’s disease”. Alzheimer’s disease is a neurodegenerative disorder characterized by cognitive and behavioral problems.

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *